Dopl Technologies raised $6.3 million in seed funding led by SpringTide Ventures to advance a telerobotic ultrasound platform toward FDA clearance. The system, called Traverse, lets sonographers remotely operate a robotic arm via haptic controllers and cameras to perform diagnostic ultrasound exams on patients at distant sites. The platform is hardware-agnostic, integrating off-the-shelf robots and […]This story continues at The Next Web